• Welcome to Phoenix Rising!

    Created in 2008, Phoenix Rising is the largest and oldest forum dedicated to furthering the understanding of, and finding treatments for, complex chronic illnesses such as chronic fatigue syndrome (ME/CFS), fibromyalgia, long COVID, postural orthostatic tachycardia syndrome (POTS), mast cell activation syndrome (MCAS), and allied diseases.

    To become a member, simply click the Register button at the top right.

New Prescription Treatments for Leaky Gut are On the Horizon

MonkeyMan

Senior Member
Messages
405
One is called linaclotide... see http://www.longecity.org/forum/topi...r-may-prevent-cancer-in-the-rest-of-the-body/ ... hopefully will be available in 2013.

However, linaclotide can cause severe diarrhea. Another drug, called plecanatide, is a bit farther off, but it doesn't have the same issue with diarrhea... see http://ibs.about.com/od/medication/p/Plecanatide-For-Chronic-Constipation.htm

Also, further down the pike, is larazotide, which is being tested in patients with celiac disease. It's only in Phase 2 trials, so it's years away from approval. See http://celiacdisease.about.com/od/CeliacDiseaseDrugs/a/Celiac-Disease-Drugs-In-Development.htm

Drew
 

MonkeyMan

Senior Member
Messages
405
Another drug to keep an eye on is vercirnon, (also known as Traficet-EN) for Crohn's Disease, which is currently in Phase III trials. "Three pivotal studies and an open label study are underway with results expected in 2H 2013. By blocking the chemokine receptor CCR9, Traficet-EN prevents lymphocytes from homing to sites of inflammation in the gut". See http://www.businesswire.com/news/rx...emoCentryxs-GSKs-Traficet-EN-Vercirnon-Crohns

Drew